BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 33728532)

  • 1. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis.
    Xue B; Wu S; Zhang M; Hong J; Liu B; Xu N; Zeng Q; Tang K; Zheng X
    Abdom Radiol (NY); 2021 Aug; 46(8):3835-3844. PubMed ID: 33728532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Radiomic-Based Model for Prediction of Intrahepatic Cholangiocarcinoma in Patients With Intrahepatic Lithiasis Complicated by Imagologically Diagnosed Mass.
    Xue B; Wu S; Zheng M; Jiang H; Chen J; Jiang Z; Tian T; Tu Y; Zhao H; Shen X; Ramen K; Wu X; Zhang Q; Zeng Q; Zheng X
    Front Oncol; 2020; 10():598253. PubMed ID: 33489897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
    Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation combined hepatocellular and cholangiocarcinoma from intrahepatic cholangiocarcinoma based on radiomics machine learning.
    Zhang J; Huang Z; Cao L; Zhang Z; Wei Y; Zhang X; Song B
    Ann Transl Med; 2020 Feb; 8(4):119. PubMed ID: 32175412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.
    Ji GW; Zhu FP; Zhang YD; Liu XS; Wu FY; Wang K; Xia YX; Zhang YD; Jiang WJ; Li XC; Wang XH
    Eur Radiol; 2019 Jul; 29(7):3725-3735. PubMed ID: 30915561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma.
    Chu H; Liu Z; Liang W; Zhou Q; Zhang Y; Lei K; Tang M; Cao Y; Chen S; Peng S; Kuang M
    Eur Radiol; 2021 Apr; 31(4):2368-2376. PubMed ID: 33033863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
    Zhou Y; Zhou G; Zhang J; Xu C; Wang X; Xu P
    Eur Radiol; 2021 Sep; 31(9):6846-6855. PubMed ID: 33638019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study.
    Bo Z; Chen B; Yang Y; Yao F; Mao Y; Yao J; Yang J; He Q; Zhao Z; Shi X; Chen J; Yu Z; Yang Y; Wang Y; Chen G
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2501-2513. PubMed ID: 36922449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver Metastases.
    Xu Y; Ye F; Li L; Yang Y; Ouyang J; Zhou Y; Wang S; Xie L; Zhou J; Zhao H; Zhao X
    Acad Radiol; 2023 Sep; 30(9):2010-2020. PubMed ID: 37414635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics.
    Qian X; Zhou C; Wang F; Lu X; Zhang Y; Chen L; Zeng M
    Radiol Med; 2023 Mar; 128(3):274-288. PubMed ID: 36773271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Mahmoudi S; Bernatz S; Ackermann J; Koch V; Dos Santos DP; Grünewald LD; Yel I; Martin SS; Scholtz JE; Stehle A; Walter D; Zeuzem S; Wild PJ; Vogl TJ; Kinzler MN
    Clin Oncol (R Coll Radiol); 2023 May; 35(5):e312-e318. PubMed ID: 36804153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive prediction of perineural invasion in intrahepatic cholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study.
    Liu Z; Luo C; Chen X; Feng Y; Feng J; Zhang R; Ouyang F; Li X; Tan Z; Deng L; Chen Y; Cai Z; Zhang X; Liu J; Liu W; Guo B; Hu Q
    Int J Surg; 2024 Feb; 110(2):1039-1051. PubMed ID: 37924497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma.
    Liang W; Xu L; Yang P; Zhang L; Wan D; Huang Q; Niu T; Chen F
    Front Oncol; 2018; 8():360. PubMed ID: 30234019
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.
    Huang JL; Sun Y; Wu ZH; Zhu HJ; Xia GJ; Zhu XS; Wu JH; Zhang KH
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10161-10168. PubMed ID: 37268850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study.
    Dai Y; Cheng Y; Zhou Z; Li Z; Luo Y; Qiu H
    PeerJ; 2023; 11():e16230. PubMed ID: 37849829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma.
    Qian X; Lu X; Ma X; Zhang Y; Zhou C; Wang F; Shi Y; Zeng M
    Front Oncol; 2022; 12():838701. PubMed ID: 35280821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Chen X; Chen Y; Chen H; Zhu J; Huang R; Xie J; Zhang T; Xie A; Li Y
    Abdom Radiol (NY); 2023 Aug; 48(8):2525-2536. PubMed ID: 37169988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contract-enhanced CT-based radiomics for differentiation of pancreatobiliary-type and intestinal-type periampullary carcinomas.
    Bi L; Yang L; Ma J; Cai S; Li L; Huang C; Xu J; Wang X; Huang M
    Clin Radiol; 2022 Jan; 77(1):e75-e83. PubMed ID: 34753589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis.
    Park HS; Lee JM; Kim SH; Jeong JY; Kim YJ; Lee KH; Choi SH; Han JK; Choi BI
    AJR Am J Roentgenol; 2006 Aug; 187(2):445-53. PubMed ID: 16861550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation.
    Mosconi C; Cucchetti A; Bruno A; Cappelli A; Bargellini I; De Benedittis C; Lorenzoni G; Gramenzi A; Tarantino FP; Parini L; Pettinato V; Modestino F; Peta G; Cioni R; Golfieri R
    Eur Radiol; 2020 Aug; 30(8):4534-4544. PubMed ID: 32227266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.